All lobbying filings

FORBES-TATE

FORBES-TATE filed a Q4 report for WALGREENS CO. on January 19, 2026, reporting $50,000 in lobbying income.

Lobbying for WALGREENS CO. · An American company that operates as the second-largest pharmacy store chain.

All filings by FORBES-TATE · Everything WALGREENS CO. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to vaccines; Issues related to the FDA certification process; Issues related to Pharmacy Benefit Managers.

Medicare/Medicaid

Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Pharmacy Benefit Managers.

Taxation/Internal Revenue Code

Issues related to corporate tax, net operating loss, EBITA/EBIDA.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.